KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Revenue (2016 - 2025)

Teladoc Health (TDOC) has disclosed Revenue for 12 consecutive years, with $642.3 million as the latest value for Q4 2025.

  • Quarterly Revenue changed 0.28% to $642.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, down 1.54% year-over-year, with the annual reading at $2.5 billion for FY2025, 1.54% down from the prior year.
  • Revenue hit $642.3 million in Q4 2025 for Teladoc Health, up from $626.4 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $660.5 million in Q4 2023 to a low of $453.7 million in Q1 2021.
  • Historically, Revenue has averaged $607.1 million across 5 years, with a median of $630.6 million in 2025.
  • Biggest five-year swings in Revenue: skyrocketed 150.93% in 2021 and later dropped 3.03% in 2024.
  • Year by year, Revenue stood at $554.2 million in 2021, then grew by 15.06% to $637.7 million in 2022, then grew by 3.58% to $660.5 million in 2023, then decreased by 3.03% to $640.5 million in 2024, then grew by 0.28% to $642.3 million in 2025.
  • Business Quant data shows Revenue for TDOC at $642.3 million in Q4 2025, $626.4 million in Q3 2025, and $631.9 million in Q2 2025.